Deep Track Capital’s Genmab GMAB Stock Holding History

Deep Track Capital’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$82.4M	Buy	+3,000,000	New	+$79.7M	1.2%	31

Other funds holding GMAB

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return

Deep Track Capital's GMAB Position: Q2 2026 in Review

Deep Track Capital increased its Genmab (GMAB) stake by 54% in Q2 2026, buying an estimated $52.8M and bringing the position to 5,650,000 shares worth $155M. The position accounts for 2.26% of the portfolio, ranked #19.

Deep Track Capital first reported a position in GMAB in Q4 2024 and has held it in 4 quarters since. 292 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

Deep Track Capital held 5,650,000 shares of Genmab worth $155M as of Q2 2026.
Deep Track Capital bought 1,986,750 Genmab shares in Q2 2026, an estimated $52.8M.
Genmab made up 2.26% of Deep Track Capital's portfolio in Q2 2026, its #19 holding.
Deep Track Capital first reported a position in Genmab in Q4 2024 and has held it in 4 quarters since.
292 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Deep Track Capital's 13F filing for Q2 2026, filed 14 Aug 2026.